Product Code: ETC13370041 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Vaccine Market was valued at USD 68.7 Billion in 2024 and is expected to reach USD 110.5 Billion by 2031, growing at a compound annual growth rate of 5.70% during the forecast period (2025-2031).
The Global Vaccine Market is experiencing significant growth driven by increasing awareness about preventive healthcare, rising prevalence of infectious diseases, and government initiatives to promote immunization programs. The market is dominated by key players such as GlaxoSmithKline, Pfizer, Merck, and Sanofi Pasteur, who invest heavily in research and development to introduce innovative vaccines. The COVID-19 pandemic has further boosted the demand for vaccines, leading to accelerated development and distribution efforts worldwide. Technological advancements, favorable reimbursement policies, and expanding vaccination coverage in emerging economies are also fueling market expansion. However, challenges such as vaccine hesitancy, stringent regulatory requirements, and high costs of vaccine development and production pose potential obstacles to market growth. Overall, the Global Vaccine Market is poised for continued expansion in the coming years, driven by the necessity for disease prevention and public health initiatives.
The Global Vaccine Market is witnessing significant growth driven by the increasing prevalence of infectious diseases and the growing focus on preventive healthcare. Key trends include the rising demand for vaccines due to the COVID-19 pandemic, the development of new technologies such as mRNA vaccines, and the expansion of immunization programs in emerging markets. Opportunities in the market include the development of novel vaccines for diseases with unmet medical needs, the adoption of combination vaccines for improved efficacy and convenience, and investments in vaccine production capacity to meet the rising demand. Additionally, collaborations between pharmaceutical companies and government organizations to improve vaccine accessibility and distribution are expected to drive market growth in the coming years.
The Global Vaccine Market faces several challenges, including vaccine hesitancy driven by misinformation and lack of access to vaccines in certain regions. Manufacturing and distribution challenges often lead to supply shortages, impacting global vaccination efforts. Additionally, high costs associated with research and development, as well as regulatory hurdles, pose barriers to the entry of new vaccines into the market. Competition among vaccine manufacturers, especially for diseases with multiple available vaccines, can also create pricing pressures and market saturation. Furthermore, addressing public health emergencies such as pandemics requires rapid vaccine development and deployment, which can strain existing infrastructure and resources. Overall, navigating these challenges requires collaboration among stakeholders, investment in research and development, and innovative strategies to ensure equitable access to vaccines worldwide.
The Global Vaccine Market is primarily driven by increasing investments in research and development for the development of new vaccines to combat infectious diseases and prevent outbreaks. Rising prevalence of various diseases, growing awareness about the importance of immunization, and government initiatives to promote vaccination programs also contribute to market growth. Additionally, technological advancements in vaccine production, expanding initiatives for vaccination campaigns in developing countries, and the emergence of novel vaccine delivery systems are further propelling market expansion. The ongoing COVID-19 pandemic has also significantly boosted the demand for vaccines globally, leading to accelerated innovation and production capabilities. Overall, the increasing focus on preventive healthcare measures and the continuous efforts to address unmet medical needs are key drivers shaping the growth trajectory of the Global Vaccine Market.
Government policies related to the Global Vaccine Market vary by country and region, but common themes include regulations on vaccine approval, procurement, distribution, and pricing. Many governments have established regulatory bodies to oversee vaccine development and ensure safety and efficacy. Some countries offer subsidies or incentives to encourage vaccine research and production, while others negotiate prices with manufacturers to make vaccines more accessible. Furthermore, initiatives like the COVAX Facility aim to promote equitable access to vaccines globally, particularly in low- and middle-income countries. Governments also invest in public health campaigns to promote vaccination uptake and combat misinformation. Overall, government policies play a crucial role in shaping the landscape of the Global Vaccine Market and ensuring that vaccines reach populations in need.
The Global Vaccine Market is expected to experience significant growth in the coming years due to increasing awareness about preventive healthcare, rising investments in research and development for new vaccines, and the ongoing focus on immunization programs worldwide. The COVID-19 pandemic has further highlighted the importance of vaccines, leading to accelerated vaccine development and distribution efforts. Technological advancements such as the development of mRNA vaccines and innovative delivery systems are also driving market growth. Additionally, government initiatives and collaborations between pharmaceutical companies and healthcare organizations are expected to further boost market expansion. However, challenges such as vaccine hesitancy, regulatory hurdles, and supply chain issues may impact market growth. Overall, the Global Vaccine Market is poised for substantial growth in the foreseeable future.
In the global vaccine market, each region presents unique opportunities and challenges. Asia is a key growth market due to increasing healthcare expenditure and government initiatives to expand immunization programs. North America dominates the market with advanced healthcare infrastructure and high adoption rates. Europe is characterized by stringent regulatory frameworks and a focus on preventive healthcare. The Middle East and Africa region shows growing awareness about vaccination benefits, driven by initiatives to combat infectious diseases. Latin America is witnessing increasing investments in healthcare infrastructure, boosting vaccine demand. However, challenges such as access barriers and vaccine hesitancy exist across all regions, requiring targeted strategies for market penetration and education to drive vaccination rates and overall market growth.
Global Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Vaccine Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Global Vaccine Market - Industry Life Cycle |
3.4 Global Vaccine Market - Porter's Five Forces |
3.5 Global Vaccine Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Global Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Global Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Global Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Global Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Vaccine Market Trends |
6 Global Vaccine Market, 2021 - 2031 |
6.1 Global Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Vaccine Market, Revenues & Volume, By Preventive Vaccines, 2021 - 2031 |
6.1.3 Global Vaccine Market, Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031 |
6.1.4 Global Vaccine Market, Revenues & Volume, By DNA Vaccines, 2021 - 2031 |
6.2 Global Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Vaccine Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.3 Global Vaccine Market, Revenues & Volume, By COVID19, 2021 - 2031 |
6.2.4 Global Vaccine Market, Revenues & Volume, By Hepatitis B, 2021 - 2031 |
6.3 Global Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Vaccine Market, Revenues & Volume, By Pediatrics, 2021 - 2031 |
6.3.3 Global Vaccine Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.3.4 Global Vaccine Market, Revenues & Volume, By Geriatrics, 2021 - 2031 |
6.4 Global Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Vaccine Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.4.3 Global Vaccine Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.4.4 Global Vaccine Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.5 Global Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Vaccine Market, Revenues & Volume, By mRNAbased, 2021 - 2031 |
6.5.3 Global Vaccine Market, Revenues & Volume, By Viral Vector, 2021 - 2031 |
6.5.4 Global Vaccine Market, Revenues & Volume, By Protein Subunit, 2021 - 2031 |
7 North America Vaccine Market, Overview & Analysis |
7.1 North America Vaccine Market Revenues & Volume, 2021 - 2031 |
7.2 North America Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Vaccine Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.5 North America Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.6 North America Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Latin America (LATAM) Vaccine Market, Overview & Analysis |
8.1 Latin America (LATAM) Vaccine Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Vaccine Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
8.5 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8.6 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.7 Latin America (LATAM) Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
9 Asia Vaccine Market, Overview & Analysis |
9.1 Asia Vaccine Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Vaccine Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
9.5 Asia Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
9.6 Asia Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.7 Asia Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
10 Africa Vaccine Market, Overview & Analysis |
10.1 Africa Vaccine Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Vaccine Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
10.5 Africa Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
10.6 Africa Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.7 Africa Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
11 Europe Vaccine Market, Overview & Analysis |
11.1 Europe Vaccine Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Vaccine Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
11.5 Europe Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
11.6 Europe Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.7 Europe Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
12 Middle East Vaccine Market, Overview & Analysis |
12.1 Middle East Vaccine Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Vaccine Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Vaccine Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
12.5 Middle East Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
12.6 Middle East Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.7 Middle East Vaccine Market, Revenues & Volume, By Technology, 2021 - 2031 |
13 Global Vaccine Market Key Performance Indicators |
14 Global Vaccine Market - Export/Import By Countries Assessment |
15 Global Vaccine Market - Opportunity Assessment |
15.1 Global Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
15.4 Global Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
15.5 Global Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.6 Global Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
16 Global Vaccine Market - Competitive Landscape |
16.1 Global Vaccine Market Revenue Share, By Companies, 2024 |
16.2 Global Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |